Company

Company

Mirabilis Medical is the developer of a non-invasive therapeutic ultrasound platform with an initial application to the treatment of uterine fibroids. Symptomatic uterine fibroids affect approximately 25% of all women at some point in their lives,1 and can cause pain, abnormal bleeding, pregnancy loss, and infertility.2
The Mirabilis platform uses high resolution ultrasound imaging to localize treatment, and a proprietary ultrasound technology to quickly and non-invasively treat tissue deep in the body. The company believes that this treatment modality has several other potential clinical applications.
1 Laughlin KL, Stewart EA. Uterine Leiomyomas. Obstet Gynecol 2011;117:396-403
2 Brahma PK, Martel KM. Future Directions in Myoma Research. Obstet Gynecol Clin 2006;33:199-244

Caution: The Mirabilis System is limited by federal law to investigatinoal use in the United States.